Article info

Download PDFPDF

Short report
Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors

Authors

  1. Correspondence to Dr Guru Sonpavde; gurup_sonpavde{at}dfci.harvard.edu
View Full Text

Citation

Nuzzo PV, Pond GR, Abou Alaiwi S, et al
Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors

Publication history

  • Accepted March 3, 2020
  • First published March 30, 2020.
Online issue publication 
March 30, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.